These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 32387915)
1. Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats. Chandler CM; Maggio SE; Peng H; Nixon K; Bardo MT Drug Alcohol Depend; 2020 Jul; 212():107988. PubMed ID: 32387915 [TBL] [Abstract][Full Text] [Related]
2. An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI. Maggio SE; Saunders MA; Nixon K; Prendergast MA; Zheng G; Crooks PA; Dwoskin LP; Bell RL; Bardo MT Drug Alcohol Depend; 2018 Dec; 193():154-161. PubMed ID: 30384323 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats. Waeiss RA; Knight CP; Hauser SR; Pratt LA; McBride WJ; Rodd ZA Psychopharmacology (Berl); 2019 Jun; 236(6):1887-1900. PubMed ID: 30758525 [TBL] [Abstract][Full Text] [Related]
4. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292 [TBL] [Abstract][Full Text] [Related]
5. Effects of adolescent alcohol exposure via oral gavage on adult alcohol drinking and co-use of alcohol and nicotine in Sprague Dawley rats. Chandler CM; Hamid U; Maggio SE; Peng H; Pauly JR; Beckmann J; Nixon K; Bardo MT Drug Alcohol Depend; 2022 Mar; 232():109298. PubMed ID: 35038606 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial. Ray LA; Green R; Enders C; Leventhal AM; Grodin EN; Li G; Lim A; Hartwell E; Venegas A; Meredith L; Nieto SJ; Shoptaw S; Ho D; Miotto K Am J Psychiatry; 2021 Sep; 178(9):818-828. PubMed ID: 34080890 [TBL] [Abstract][Full Text] [Related]
7. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats. Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997 [TBL] [Abstract][Full Text] [Related]
8. Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure. Ginsburg BC; Lamb RJ Alcohol Clin Exp Res; 2013 Jul; 37(7):1228-33. PubMed ID: 23413834 [TBL] [Abstract][Full Text] [Related]
9. Development of an oral operant nicotine/ethanol co-use model in alcohol-preferring (p) rats. Hauser SR; Katner SN; Deehan GA; Ding ZM; Toalston JE; Scott BJ; Bell RL; McBride WJ; Rodd ZA Alcohol Clin Exp Res; 2012 Nov; 36(11):1963-72. PubMed ID: 22486609 [TBL] [Abstract][Full Text] [Related]
10. The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol. June HL; McCane SR; Zink RW; Portoghese PS; Li TK; Froehlich JC Psychopharmacology (Berl); 1999 Nov; 147(1):81-9. PubMed ID: 10591872 [TBL] [Abstract][Full Text] [Related]
11. The Effects of Long-Term Varenicline Administration on Ethanol and Sucrose Seeking and Self-Administration in Male P Rats. Czachowski CL; Froehlich JC; DeLory M Alcohol Clin Exp Res; 2018 Feb; 42(2):453-460. PubMed ID: 29168193 [TBL] [Abstract][Full Text] [Related]
12. Voluntary Binge Consumption of Ethanol in a Sweetened, Chocolate-Flavored Solution by Male and Female Adolescent Sprague Dawley Rats. Hosová D; Spear LP Alcohol Clin Exp Res; 2017 Mar; 41(3):541-550. PubMed ID: 28195335 [TBL] [Abstract][Full Text] [Related]
13. Commonality of Ethanol and Nicotine Reinforcement and Relapse in Wistar-Derived UChB Rats: Inhibition by N-Acetylcysteine. Quintanilla ME; Morales P; Ezquer F; Ezquer M; Herrera-Marschitz M; Israel Y Alcohol Clin Exp Res; 2018 Oct; 42(10):1988-1999. PubMed ID: 30035805 [TBL] [Abstract][Full Text] [Related]
14. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence. Matzeu A; Terenius L; Martin-Fardon R Alcohol Clin Exp Res; 2018 Dec; 42(12):2466-2478. PubMed ID: 30320880 [TBL] [Abstract][Full Text] [Related]
15. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats. Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178 [TBL] [Abstract][Full Text] [Related]
16. Increased alcohol preference and intake in nicotine-preferring rats. Ozturk B; Pogun S; Kanit L Am J Drug Alcohol Abuse; 2020 Jul; 46(4):408-420. PubMed ID: 31860364 [TBL] [Abstract][Full Text] [Related]
17. Operant self-administration of sweetened ethanol and time course of blood ethanol levels in adolescent and adult male Long-Evans rats. Doherty JM; Gonzales RA Alcohol Clin Exp Res; 2015 Mar; 39(3):485-95. PubMed ID: 25702920 [TBL] [Abstract][Full Text] [Related]
18. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice. Navarro M; Luhn KL; Kampov-Polevoy AB; Garbutt JC; Thiele TE Alcohol Clin Exp Res; 2019 May; 43(5):783-790. PubMed ID: 30817015 [TBL] [Abstract][Full Text] [Related]
19. Do rat strain differences in ethanol consumption reflect differences in ethanol sensitivity or the preparedness to learn? Gauvin DV; Moore KR; Holloway FA Alcohol; 1993; 10(1):37-43. PubMed ID: 8447965 [TBL] [Abstract][Full Text] [Related]
20. Oral operant ethanol self-administration in the absence of explicit cues, food restriction, water restriction and ethanol fading in C57BL/6J mice. Stafford AM; Anderson SM; Shelton KL; Brunzell DH Psychopharmacology (Berl); 2015 Oct; 232(20):3783-95. PubMed ID: 26268145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]